WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 16%
  • Publisher: 66%

A World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective. WHO data shows Omicron, which is evading protection provided by many v

Singapore Headlines News

Singapore Latest News, Singapore Headlines

A World Health Organization panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.

The panel on Thursday strongly recommended Lilly's baricitinib, sold under brand name Olumiant, for patients with severe COVID-19 in combination with corticosteroids, while conditionally endorsed GSK-Vir's antibody therapy for non-severe patients at the highest risk of hospitalisation. The WHO experts noted that the effectiveness of monoclonal antibody treatments - lab-generated compounds that mimic the body's natural defences - against new variants such as Omicron was still uncertain, and said the guidelines for this class of medicine will be updated when additional data become available.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.